Welcome to PetForums

Join thousands of other pet owners and pet lovers on the UK's most popular and friendly pet community and discussion forum.

Sign Up

BUAV: Cruel rabbit skin irritation test is finally replaced

Discussion in 'Pet News' started by testmg80, Jul 23, 2009.


  1. testmg80

    testmg80 PetForums VIP

    Joined:
    Jul 29, 2008
    Messages:
    1,441
    Likes Received:
    31
    BUAV: European Commission finally approves in vitro methods for REACH: Cruel rabbit skin irritation test is finally replaced

    The BUAV has today welcomed the announcement by the European Commission of the adoption into EU regulation of an alternative to the cruel rabbit skin irritation test. This means that it is no longer permissible to use rabbits to test the irritation of chemicals, biocides and cosmetics.

    The alternative is an in vitro method using skin donated from human volunteers. It is commercially available as EpiSkin, EpiDerm and SkinEthic.

    Animal protection groups have been strongly pressing for the EU to finally accept the new method, which was validated by the European Centre for the Validation of Alternative Methods in April 2007. We are disappointed, however, that it has take over 2 years for a valid and commercially available method to receive regulatory approval in the EU.

    Chief Executive of the BUAV, Michelle Thew states: “The BUAV welcomes this important step forward in eliminating cruel animal tests. Last year 740 rabbits were used in such skin irritation tests in the UK. We are now calling on the Home Office to immediately stop this cruel rabbit skin test from taking place in the UK.”

    For further information please contact the BUAV press office.
    Home, BUAV

    For more information contact:

    Dr Katy Taylor +44 (0) 207 700 4888

    Out of hours mobile: 07850 510 955 / Email: katy.taylor@buav.org
    View attachment BUAV.bmp
     
  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice